Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Nov 9;17(11):1868.
doi: 10.3390/ijms17111868.

Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells

Affiliations

Stearoyl-CoA Desaturase-1 Protects Cells against Lipotoxicity-Mediated Apoptosis in Proximal Tubular Cells

Tamaki Iwai et al. Int J Mol Sci. .

Abstract

Saturated fatty acid (SFA)-related lipotoxicity is a pathogenesis of diabetes-related renal proximal tubular epithelial cell (PTEC) damage, closely associated with a progressive decline in renal function. This study was designed to identify a free fatty acid (FFA) metabolism-related enzyme that can protect PTECs from SFA-related lipotoxicity. Among several enzymes involved in FFA metabolism, we identified stearoyl-CoA desaturase-1 (SCD1), whose expression level significantly decreased in the kidneys of high-fat diet (HFD)-induced diabetic mice, compared with non-diabetic mice. SCD1 is an enzyme that desaturates SFAs, converting them to monounsaturated fatty acids (MUFAs), leading to the formation of neutral lipid droplets. In culture, retrovirus-mediated overexpression of SCD1 or MUFA treatment significantly ameliorated SFA-induced apoptosis in PTECs by enhancing intracellular lipid droplet formation. In contrast, siRNA against SCD1 exacerbated the apoptosis. Both overexpression of SCD1 and MUFA treatment reduced SFA-induced apoptosis via reducing endoplasmic reticulum stress in cultured PTECs. Thus, HFD-induced decrease in renal SCD1 expression may play a pathogenic role in lipotoxicity-induced renal injury, and enhancing SCD1-mediated desaturation of SFA and subsequent formation of neutral lipid droplets may become a promising therapeutic target to reduce SFA-induced lipotoxicity. The present study provides a novel insight into lipotoxicity in the pathogenesis of diabetic nephropathy.

Keywords: desaturation; free fatty acid; lipid droplet; lipotoxicity; proximal tubular epithelial cells.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Body weight (A) and blood glucose levels (B) of mice fed with either normal diet (ND, n = 5) or high-fat diet (HFD, n = 5); (C) Expression levels of mRNAs related to lipid metabolism in the kidneys of mice fed an ND or a HFD. Data are expressed as a relative ratio to the ND group; (D) Representative immunoblot of SCD1 and ADRP. β-actin was used as a loading control; (E) Quantitative results of the immunoblots. Data are expressed as a relative ratio to the ND group. p < 0.05 indicates statistical significance; (F) Immunohistological analysis of SCD1 in kidney sections of mice fed an ND or a HFD. Magnification: ×40 (upper), ×200 (lower). Data are shown as mean ± SD. p < 0.05 indicates statistical significance. NS indicates no significance. CPT1, carnitine palmitoyltransferase 1; ACO, acetyl coenzyme A oxidase; MCAD, medium-chain acyl-CoA dehydrogenase; FAS, fatty acid synthase; ACC, acetyl-CoA carboxylase; SCD, stearoyl-CoA desaturase; DGAT, diacylglycerol transferase; ADRP, adipose differentiation-related protein.
Figure 2
Figure 2
(A) Schema representing the formation of neutral lipid droplets from saturated free fatty acids (FAs) such as palmitate and stearate; (B) Representative immunoblot of cleaved caspase 3 and SCD1 in cultured proximal tubular cells infected with the control retrovirus (pBABE-CONT) or the retrovirus for SCD1 overexpression (pBABE-SCD1), and treated with/without palmitate or oleate. β-actin was used as a loading control; (C) Quantitative result of cleaved caspase 3 (n = 5); (D) Representative pictures of TUNEL staining under the indicated conditions. White arrows indicate TUNEL-positive apoptotic cells; (E) Quantitative results of TUNEL staining; (F) Representative immunoblot of cleaved caspase 3 and SCD1 in cultured proximal tubular cells transfected with the control siRNA or siRNA against SCD1, and treated with/without palmitate or oleate; (G) Quantitative result of cleaved caspase 3 (n = 7). SCD, stearoyl-CoA desaturase. Data are shown as mean ± SD. p < 0.05 indicates statistical significance.
Figure 3
Figure 3
(A) Representative immunoblot of pPERK, PERK, sXBP1 and CHOP in cultured proximal tubular cells infected with the control retrovirus (pBABE-CONT) or the retrovirus for SCD1 overexpression (pBABE-SCD1), and treated with/without palmitate or oleate. β-actin was used as a loading control. Quantitative results of the pPERK/PERK ratio (B), sXBP1 (C) and CHOP (D) (n = 4). Data are shown as mean ± SD. p < 0.05 indicates statistical significance. pPERK, PKR-like ER kinase (PERK) phosphorylated at Thr980; sXBP1, spliced X-box binding protein 1; CHOP, C/EBP homologous protein; SCD, stearoyl-CoA desaturase.
Figure 4
Figure 4
(A) Representative BODIPY staining for visualizing intracellular neutral lipid accumulation in cultured proximal tubular cells infected with the control retrovirus (pBABE-CONT) or the retrovirus for SCD1 overexpression (pBABE-SCD1), and treated with/without palmitate or oleate; (B) mRNA expression levels of DGAT1, DGAT2 and ADRP (n = 6). Data are shown as mean ± SD. NS indicates no significance. DGAT, diacylglycerol transferase; ADRP, adipose differentiation-related protein.
Figure 5
Figure 5
(A) Representative immunoblot of ADRP in cultured proximal tubular cells infected with the control retrovirus (pBABE-CONT) or the retrovirus for ADRP overexpression (pBABE-ADRP); (B) Representative immunoblot of cleaved caspase 3, pPERK, PERK and CHOP in pBABE-CONT or pBABE-ADRP transfected cells, treated with/without palmitate. β-actin was used as a loading control; Quantitative results of cleaved caspase 3 (C), pPERK/PERK ratio (D) and CHOP (E) (n = 4); (F) Representative pictures of TUNEL staining for detecting apoptotic cells in pBABE-CONT or pBABE-ADRP transfected cells, treated with/without palmitate. White arrows indicate TUNEL-positive apoptotic cells; (G) Quantitative results of TUNEL staining. Data are shown as mean ± SD. p < 0.05 indicates statistical significance. ADRP, adipose differentiation-related protein; pPERK, PKR-like ER kinase (PERK) phosphorylated at Thr980; CHOP, C/EBP homologous protein; SCD, stearoyl-CoA desaturase.
Figure 6
Figure 6
Schema showing the renoprotective mechanism of SCD1 against saturated fatty acid (SFA)-bound albumin-induced proximal tubular epithelial cell (PTEC) damage in type 2 diabetic nephropathy. Systemic alteration in FFA metabolism increases urinary SFA-related lipotoxicity. Furthermore, diabetic conditions alter intrarenal FA metabolism, characterized by SCD1 deficiency, enhancing ER stress-related PTEC damage. SCD1 activation may ameliorate SFA-induced PTEC damage via enhancing desaturation and subsequent lipid droplet formation.

References

    1. Nath K.A. Tubulointerstitial changes as a major determinant in the progression of renal damage. Am. J. Kidney Dis. 1992;20:1–17. doi: 10.1016/S0272-6386(12)80312-X. - DOI - PubMed
    1. Abbate M., Zoja C., Remuzzi G. How does proteinuria cause progressive renal damage? J. Am. Soc. Nephrol. 2006;17:2974–2984. doi: 10.1681/ASN.2006040377. - DOI - PubMed
    1. Diabetes Control and Complications Trial Research Group The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The diabetes control and complications trial research group. N. Engl. J. Med. 1993;329:977–986. - PubMed
    1. Brenner B.M., Cooper M.E., de Zeeuw D., Keane W.F., Mitch W.E., Parving H.H., Remuzzi G., Snapinn S.M., Zhang Z., Shahinfar S., et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 2001;345:861–869. doi: 10.1056/NEJMoa011161. - DOI - PubMed
    1. Araki S., Haneda M., Sugimoto T., Isono M., Isshiki K., Kashiwagi A., Koya D. Factors associated with frequent remission of microalbuminuria in patients with type 2 diabetes. Diabetes. 2005;54:2983–2987. doi: 10.2337/diabetes.54.10.2983. - DOI - PubMed

MeSH terms

LinkOut - more resources